Albuterol 0.417 MG/ML Inhalation Solution — RxCUI 351136
RxNorm drug concept · Semantic clinical drug
RxCUI 351136
Semantic clinical drug · SCD
● Current RxNorm concept 16 FDA products
22 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI351136
Official nameAlbuterol 0.417 MG/ML Inhalation Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asalbuterol 0.042 % (1.25 MG/3 ML) Inhalation Solution; albuterol sulfate 0.042 % (1.25 MG/3 ML) Inhalation Solution; albuterol 1.25 MG (albuterol sulfate 1.5 MG) per 3 ML Inhalation Solution
FDA products mapped16
Package NDCs mapped22
Reported Medicaid activity (SDUD)552,677 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Albuterol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Albuterol opens up your airways when the muscles around them tighten (bronchospasm), as in asthma. Inhalers and powders are also used before exercise to prevent exercise-induced br...
- It is breathed in through your mouth. The usual pattern for bronchospasm is a couple of puffs every 4 to 6 hours, and before exercise it is used 15 to 30 minutes ahead. Some inhale...
- The most common are throat irritation, cough, upper respiratory irritation, viral respiratory infections and muscle or bone aches. These are usually manageable. Call me or your doc...
- Get help right away if your breathing gets worse after a dose, or if you have hives, swelling of the face or throat, or chest pain or a racing heartbeat. Also call your doctor if y...
🕸️ Concept Web — How Albuterol 0.417 MG/ML Inhalation Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Albuterol 0.417 MG/ML Inhalation Solution
RxCUI 351136 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Albuterol
435IN
-
Albuterol
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Albuterol Inhalation Solution
2108226SCDF -
Albuterol Inhalant Product
1154602SCDG -
Inhalation Solution
346161DF -
Inhalant Product
1151123DFG
-
Albuterol Inhalation Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Albuterol 0.417 MG/ML
360330SCDC
-
Albuterol 0.417 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Albuterol 0.417 MG/ML
SCDC · 360330 -
Albuterol Inhalation Solution
SCDF · 2108226 -
Albuterol Inhalant Product
SCDG · 1154602
📦 FDA Products & Package NDCs
16 products · 22 package NDCs
22 package NDCs map to RxCUI 351136 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-7057-52 | 5 POUCH in 1 CARTON (0378-7057-52) / 5 VIAL in 1 POUCH (037... | Albuterol | Mylan Pharmaceuticals Inc. | 2022-10-07 |
| 00378-7058-52 | 5 POUCH in 1 CARTON (0378-7058-52) / 5 VIAL in 1 POUCH (037... | Albuterol | Mylan Pharmaceuticals Inc. | 2022-10-07 |
| 00487-0301-01 | 30 POUCH in 1 CARTON (0487-0301-01) / 1 VIAL, SINGLE-DOSE i... | Albuterol Sulfate | Nephron Pharmaceuticals Corporation | 2010-03-31 |
| 00487-9904-01 | 30 POUCH in 1 CARTON (0487-9904-01) / 1 VIAL, SINGLE-DOSE i... | Albuterol Sulfate | Nephron Pharmaceuticals Corporation | 2004-06-28 |
| 50742-0392-25 | 5 POUCH in 1 CARTON (50742-392-25) / 5 VIAL in 1 POUCH (507... | Albuterol Sulfate | Ingenus Pharmaceuticals, LLC | 2024-11-01 |
| 50742-0393-25 | 5 POUCH in 1 CARTON (50742-393-25) / 5 VIAL in 1 POUCH (507... | Albuterol Sulfate | Ingenus Pharmaceuticals, LLC | 2024-11-01 |
| 59651-0183-25 | 5 POUCH in 1 CARTON (59651-183-25) / 5 VIAL in 1 POUCH / 3... | ALBUTEROL SULFATE | Aurobindo Pharma Limited | 2020-04-20 |
| 59651-0183-30 | 6 POUCH in 1 CARTON (59651-183-30) / 5 VIAL in 1 POUCH / 3... | ALBUTEROL SULFATE | Aurobindo Pharma Limited | 2024-07-29 |
| 59651-0184-25 | 5 POUCH in 1 CARTON (59651-184-25) / 5 VIAL in 1 POUCH / 3... | ALBUTEROL SULFATE | Aurobindo Pharma Limited | 2020-04-20 |
| 59651-0184-30 | 6 POUCH in 1 CARTON (59651-184-30) / 5 VIAL in 1 POUCH / 3... | ALBUTEROL SULFATE | Aurobindo Pharma Limited | 2024-07-29 |
| 62135-0826-84 | 30 POUCH in 1 CARTON (62135-826-84) / 1 VIAL in 1 POUCH / 3... | Albuterol Sulfate | Chartwell RX, LLC | 2024-01-19 |
| 62135-0827-84 | 30 POUCH in 1 CARTON (62135-827-84) / 1 VIAL in 1 POUCH / 3... | Albuterol Sulfate | Chartwell RX, LLC | 2024-01-19 |
| 64980-0643-03 | 30 POUCH in 1 CARTON (64980-643-03) / 1 VIAL, SINGLE-DOSE i... | Albuterol Sulfate | Rising Pharma Holdings, Inc | 2025-04-30 |
| 64980-0644-02 | 25 POUCH in 1 CARTON (64980-644-02) / 1 VIAL, SINGLE-DOSE i... | Albuterol Sulfate | Rising Pharma Holdings, Inc | 2025-04-30 |
| 76204-0010-01 | 30 POUCH in 1 CARTON (76204-010-01) / 1 VIAL in 1 POUCH (76... | Albuterol Sulfate Inhalation Solution | Ritedose Pharmaceuticals, LLC | 2022-01-04 |
| 76204-0010-55 | 25 POUCH in 1 CARTON (76204-010-55) / 5 VIAL in 1 POUCH (76... | Albuterol Sulfate Inhalation Solution | Ritedose Pharmaceuticals, LLC | 2022-01-04 |
| 76204-0011-01 | 30 POUCH in 1 CARTON (76204-011-01) / 1 VIAL in 1 POUCH (76... | Albuterol Sulfate Inhalation Solution | Ritedose Pharmaceuticals, LLC | 2022-01-04 |
| 76204-0011-55 | 25 POUCH in 1 CARTON (76204-011-55) / 5 VIAL in 1 POUCH (76... | Albuterol Sulfate Inhalation Solution | Ritedose Pharmaceuticals, LLC | 2022-01-04 |
| 81894-0105-25 | 5 POUCH in 1 CARTON (81894-105-25) / 5 VIAL in 1 POUCH / 3... | ALBUTEROL SULFATE | Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | 2020-04-20 |
| 81894-0105-30 | 6 POUCH in 1 CARTON (81894-105-30) / 5 VIAL in 1 POUCH / 3... | ALBUTEROL SULFATE | Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | 2024-07-29 |
| 81894-0106-25 | 5 POUCH in 1 CARTON (81894-106-25) / 5 VIAL in 1 POUCH / 3... | ALBUTEROL SULFATE | Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | 2024-07-29 |
| 81894-0106-30 | 6 POUCH in 1 CARTON (81894-106-30) / 5 VIAL in 1 POUCH / 3... | ALBUTEROL SULFATE | Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | 2024-07-29 |
Observed labelers:
Aurobindo Pharma Limited (4) ·
Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. (4) ·
Ritedose Pharmaceuticals, LLC (4) ·
Chartwell RX, LLC (2) ·
Ingenus Pharmaceuticals, LLC (2) ·
Mylan Pharmaceuticals Inc. (2)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J7613 | Albuterol non-comp unit | 12 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.